title: Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008-2010.
abstract: BACKGROUND
  In the UK, a man's lifetime risk of being diagnosed with prostate cancer is 1 in 8. We calculated both the lifetime risk of being diagnosed with and dying from prostate cancer by major ethnic group.
  
  
  METHODS
  Public Health England provided prostate cancer incidence and mortality data for England (2008-2010) by major ethnic group. Ethnicity and mortality data were incomplete, requiring various assumptions and adjustments before lifetime risk was calculated using DevCan (percent, range).
  
  
  RESULTS
  The lifetime risk of being diagnosed with prostate cancer is approximately 1 in 8 (13.3 %, 13.2-15.0 %) for White men, 1 in 4 (29.3 %, 23.5-37.2 %) for Black men, and 1 in 13 (7.9 %, 6.3-10.5 %) for Asian men, whereas that of dying from prostate cancer is approximately 1 in 24 (4.2 %, 4.2-4.7 %) for White men, 1 in 12 (8.7 %, 7.6-10.6 %) for Black men, and 1 in 44 (2.3 %, 1.9-3.0 %) for Asian men.
  
  
  CONCLUSIONS
  In England, Black men are at twice the risk of being diagnosed with, and dying from, prostate cancer compared to White men. This is an important message to communicate to Black men. White, Black, and Asian men with a prostate cancer diagnosis are all as likely to die from the disease, independent of their ethnicity. Nonetheless, proportionally more Black men are dying from prostate cancer in England.
authors.affiliation: Evidence Team, Prostate Cancer UK, 4th Floor Counting House, 53 Tooley Street, London, UK. evidence@prostatecanceruk.org.
authors.forename: Therese
authors.initials: T
authors.lastname: Lloyd
authors.affiliation: Knowledge and Intelligence Team (South West), Public Health England, 2 Rivergate, Temple Quay, Bristol, UK. luke.hounsome@phe.gov.uk.
authors.forename: Luke
authors.initials: L
authors.lastname: Hounsome
authors.affiliation: Evidence Team, Prostate Cancer UK, 4th Floor Counting House, 53 Tooley Street, London, UK. evidence@prostatecanceruk.org.
authors.forename: Anita
authors.initials: A
authors.lastname: Mehay
authors.affiliation: Evidence Team, Prostate Cancer UK, 4th Floor Counting House, 53 Tooley Street, London, UK. evidence@prostatecanceruk.org.
authors.forename: Sarah
authors.initials: S
authors.lastname: Mee
authors.affiliation: Knowledge and Intelligence Team (South West), Public Health England, 2 Rivergate, Temple Quay, Bristol, UK. julia.verne@phe.gov.uk.
authors.forename: Julia
authors.initials: J
authors.lastname: Verne
authors.affiliation: Evidence Team, Prostate Cancer UK, 4th Floor Counting House, 53 Tooley Street, London, UK. evidence@prostatecanceruk.org.
authors.forename: Alison
authors.initials: A
authors.lastname: Cooper
mesh_terms: D000368:Aged; D004739:England / Q000453:epidemiology; D005006:Ethnicity; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000453:epidemiology*; D011634:Public Health; D012306:Risk